-
![Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative](/abs-image/US/2015/05/19/US09034876B2/abs.jpg.150x150.jpg)
1.发明授权Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative 有权用1,2,4-三唑并[1,5a]吡啶衍生物治疗慢性炎症公开(公告)号：US09034876B2
公开(公告)日：2015-05-19
申请号：US13911465
申请日：2013-06-06
Applicant: Cephalon, Inc.
Inventor： Pawel T. Dobrzanski , Matthew M. Seavey
IPC: A61K31/496 , A61K45/06
CPC classification number: A61K31/496 , A61K45/06 , A61K2300/00
Abstract: This application describes and provides a method of treating diseases or disorders characterized by chronic systemic inflammation, such as rheumatoid arthritis, using a compound that inhibits JAK2 kinase.
Abstract translation: 该申请描述并提供了使用抑制JAK2激酶的化合物治疗以慢性全身炎症为特征的疾病或病症如风湿性关节炎的方法。
-
2.发明申请公开(公告)号：US20140024655A1
公开(公告)日：2014-01-23
申请号：US13911447
申请日：2013-06-06
Applicant: Cephalon, Inc.
Inventor： Pawel T. Dobrzanski , Matthew M. Seavey
IPC: A61K31/496
CPC classification number: A61K31/496
Abstract: The present invention provides a method for treating lupus in a subject, comprising the step of administering to the subject COMPOUND A
Abstract translation: 本发明提供一种用于治疗受试者的狼疮的方法，包括给予受试者化合物A的步骤
-
公开(公告)号：US09023853B2
公开(公告)日：2015-05-05
申请号：US13911447
申请日：2013-06-06
Applicant: Cephalon, Inc.
Inventor： Pawel T. Dobrzanski , Matthew M. Seavey
IPC: A61K31/496
CPC classification number: A61K31/496
Abstract: The present invention provides a method for treating lupus in a subject, comprising the step of administering to the subject COMPOUND A.
Abstract translation: 本发明提供一种用于治疗受试者的狼疮的方法，包括给予受试者化合物A的步骤。
-
![Treatment of Chronic Inflammation with a 1,2,4-Triazolo [1,5a] Pyridine Derivative](/abs-image/US/2013/10/10/US20130267535A1/abs.jpg.150x150.jpg)
4.发明申请Treatment of Chronic Inflammation with a 1,2,4-Triazolo [1,5a] Pyridine Derivative 有权用1,2,4-三唑并[1,5a]吡啶衍生物治疗慢性炎症公开(公告)号：US20130267535A1
公开(公告)日：2013-10-10
申请号：US13911465
申请日：2013-06-06
Applicant: Cephalon, Inc.
Inventor： Pawel T. Dobrzanski , Matthew M. Seavey
IPC: A61K31/496
CPC classification number: A61K31/496 , A61K45/06 , A61K2300/00
Abstract: This application describes and provides a method of treating diseases or disorders characterized by chronic systemic inflammation, such as rheumatoid arthritis, using a compound that inhibits JAK2 kinase.
Abstract translation: 该申请描述并提供了使用抑制JAK2激酶的化合物治疗以慢性全身炎症为特征的疾病或病症如风湿性关节炎的方法。
-
-
-
Search Results
4
records
(took 0.014 seconds)
